Business
A Fully Owned Subsidiary of Sumitomo Offered to Buy the Remaining Outstanding Shares of ... - Latest Tweet by Bloomberg
The latest Tweet by Bloomberg states, 'A fully owned subsidiary of Sumitomo offered to buy the remaining outstanding shares of pharmaceutical company Myovant Sciences, seeking to bolster the development of drugs for women’s health and prostate cancer ...'
A fully owned subsidiary of Sumitomo offered to buy the remaining outstanding shares of pharmaceutical company Myovant Sciences, seeking to bolster the development of drugs for women’s health and prostate cancer https://t.co/azEHohhvj6— Bloomberg (@business) October 3, 2022
(The above story first appeared on LatestLY on Oct 03, 2022 08:23 AM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
